Irritable bowel syndrome: a gut microbiota-related disorder?

Y Bhattarai, DA Muniz Pedrogo… - American Journal of …, 2017 - journals.physiology.org
Irritable bowel syndrome (IBS) is one of the most common gastrointestinal (GI) disorders.
Despite its prevalence, the pathophysiology of IBS is not well understood although multiple …

Cytokine imbalance in irritable bowel syndrome: a systematic review and meta‐analysis

M Bashashati, N Rezaei, A Shafieyoun… - …, 2014 - Wiley Online Library
Background Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder of
unknown etiology; although infection and inflammation have recently been considered as …

Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: association with digestive symptoms and quality of life

R Choghakhori, A Abbasnezhad, A Hasanvand… - Cytokine, 2017 - Elsevier
A growing body of evidence suggests a possible role for low-grade inflammation in the
pathogenesis of irritable bowel syndrome (IBS). The objectives of this study were to measure …

The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome

Y Qu, SH Park, DC Dallas - Nutrients, 2023 - mdpi.com
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder marked by chronic
abdominal pain, bloating, and irregular bowel habits. Effective treatments are still actively …

Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?

PA Hughes, H Zola, IA Penttila… - Official journal of the …, 2013 - journals.lww.com
Irritable bowel syndrome (IBS) is a functional disorder of the gastrointestinal (GI) tract
characterized by pain or discomfort from the lower abdominal region, which is associated …

Global cytokine profiles and association with clinical characteristics in patients with irritable bowel syndrome

SMP Bennet, A Polster, H Törnblom… - Official journal of the …, 2016 - journals.lww.com
OBJECTIVES: Evidence suggests that patients with irritable bowel syndrome (IBS) have an
altered cytokine profile, although it is unclear whether cytokines are linked with symptom …

Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria

G Konstantis, S Efstathiou, C Pourzitaki, E Kitsikidou… - Clinical Nutrition, 2023 - Elsevier
Summary Background Irritable Bowel Syndrome (IBS) is a functional gastrointestinal
disorder which affects a great number of patients globally. Clinical trials and meta-analyses …

Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

SE Kim, L Chang - Neurogastroenterology & Motility, 2012 - Wiley Online Library
Background Irritable bowel syndrome and other gastrointestinal (GI) and non‐GI disorders
such as functional dyspepsia, fibromyalgia, temporomandibular joint disorder, interstitial …

[HTML][HTML] Inflammation and overlap of irritable bowel syndrome and functional dyspepsia

C Wang, X Fang - Journal of Neurogastroenterology and Motility, 2021 - ncbi.nlm.nih.gov
Irritable bowel syndrome (IBS) and functional dyspepsia (FD) are common functional
gastrointestinal disorders (FGIDs) and account for a large proportion of consulting patients …

[HTML][HTML] Current insights into the innate immune system dysfunction in irritable bowel syndrome

N Lazaridis, G Germanidis - Annals of gastroenterology, 2018 - ncbi.nlm.nih.gov
Irritable bowel syndrome (IBS) is a functional bowel disorder associated with abdominal
pain and alterations in bowel habits. The presence of IBS greatly impairs patients' quality of …